Mirae Asset Global Investments Co., Ltd. Vaxcyte, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 14,110 shares of PCVX stock, worth $597,558. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,110
Previous 13,338
5.79%
Holding current value
$597,558
Previous $503,000
8.95%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PCVX
# of Institutions
322Shares Held
139MCall Options Held
229KPut Options Held
160K-
Janus Henderson Group PLC London, X014.7MShares$622 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$508 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA12MShares$507 Million8.5% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$421 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6MShares$254 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.51B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...